Skip to Content

'
Ravi Murthy, MD

Present Title & Affiliation

Primary Appointment

Professor, Department of Interventional Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Professor, Diagnostic and Interventional Imaging, The University of Texas Medical School at Houston, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
1400 Pressler Street
Unit Number: 1471
Houston, TX 77030
Room Number: FCT14.5088
Phone: 713-745-0856
Fax: 713-792-4098
Email: rmurthy@mdanderson.org

Education & Training

Degree-Granting Education

1989 St. John's Medical College and Hospital, Bangalore, India, MD, Medicine

Postgraduate Training

2012-2013 Health Care Management Program, Rice University, Houston, TX
2002-2003 Research Fellowship, Radiological Society of North America Fellowship, American College of Radiology, Reston, VA
1997-1998 Clinical Fellowship, Vascular & Interventional Radiology, State University of New York, University Medical Center, Stony Brook, NY
1993-1997 Clinical Residency, Diagnostic Radiology, Morristown Memorial Hospital, Columbia Presbyterian College of Physicians & Surgeons, Morristown, NJ
1991-1993 Clinical Residency, Internal Medicine, Robert Wood Johnson University Hospital, New Brunswick, NJ
1990-1991 Internship, Internal Medicine, Mount Sinai School of Medicine, Elmhurst General Hospital, New York, NY
1988-1989 Rotating Internship, St. John's Medical College and Hospital, Bangalore, India

Board Certifications

2009 The American Board of Radiology, Diagnostic Radiology with Added Qualifications in Vascular and Interventional Radiology
2004 The American Board of Internal Medicine
1997 The American Board of Radiology, Diagnostic Radiology

Experience/Service

Academic Appointments

Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 9/2012-9/2013
Associate Professor, Diagnostic and Interventional Imaging, The University of Texas Medical School at Houston, Houston, TX, 2006-2012
Associate Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006-2012
Assistant Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2002-2006
Assistant Professor, Division of Vascular and Interventional Radiology, University of Maryland School of Medicine, Baltimore, MD, 1998-2002

Consultantships

Monitoring Board, ASTRA - ZENECA, Research Triangle Park, NC, 2011-present

Honors and Awards

2013 Castle Connolly Top Doctor, Castle Connolly Medical LTD
2012 2nd Place Radiopharmaceutical-Track Poster Award, The Society of Nuclear Medicine and Molecular Imaging (SNMMI)
2008 Letter of Appreciation, Seoul National University Hospital
2006-2007 Distinguished Reviewer Award, Journal of Vascular and Interventional Radiology
2004 Clinical Trials Design Workshop, American Association of Cancer Research, American Society of Clinical Oncology
2002 Association of University Radiologists Academic Development Award
2002 Fellow, American College of Physicians
1999-2002 Physician's Recognition Award, American Medical Association
1996-1997 Chief Resident, Morristown Memorial Hospital
1981 High School Valedictorian, School Captain and National Merit Scholar

Professional Memberships

American College of Radiology, Washington, DC
Reviewer, ACR Practice Guidelines for Radioembolization with Microsphere Brachytherapy Device (RMBD) for the Treatment of Liver Malignancies, 2012
Reviewer, ACR Practice Guidelines and Technical Standards, 2008
American Roentgen Ray Society, Leesburg, VA
Member, 2005-present
American Society of Clinical Oncology, Alexandria, VA
Member, 2005-present
Radiological Society of North America, Oak Brook, IL
Member of the scientific program committee, 7/2013-present
Member of the Vascular/Interventional Radiology Education Exhibits Subcommittee, 2012-2015
Member, 2001-present
Society of Interventional Radiology, Fairfax, VA
Scientific Abstract Reviewer, 2012-present
Member, 1998-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Neperud J, Mahvash A, Garg N, Murthy R, Szklaruk J. Can imaging patterns of neuroendocrine hepatic metastases predict response yttruim-90 radioembolotherapy? World J Radiol 5(6):241-247, 6/2013. PMCID: PMC3692962.
2. Smith J, Murthy R, Lahoti A, Odisio BC, Avritscher R, Chasen B, Mahvash A. Temporary balloon occlusion of the common hepatic artery for yttrium-90 glass microspheres administration in a patient with hepatocellular cancer and renal insufficiency. Case Rep Radiol 2013:560758, 4/2013. e-Pub 4/2013. PMCID: PMC3655505.
3. Overman MJ, Modak J, Kopetz S, Murthy R, Yao JC, Hicks ME, Abbruzzese JL, Tam AL. Use of Research Biopsies in Clinical Trials: Are Risks and Benefits Adequately Discussed? J Clin Oncol 31(1):17-22, 1/2013. e-Pub 11/2012. PMID: 23129736.
4. May BJ, Murthy R, Madoff DC. What's New in Transarterial Therapies for Hepatocellular Carcinoma? Gastrointest Cancer Res 5(3 Supplement 1):S14-S19, 5/2012. PMCID: PMC3413029.
5. Janne d'Othée B, Sofocleous CT, Hanna N, Lewandowski RJ, Soulen MC, Vauthey JN, Cohen SJ, Venook AP, Johnson MS, Kennedy AS, Murthy R, Geschwind JF, Kee ST. Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol 23(2):153-163, 2/2012. PMID: 22264550.
6. Mahvash A, Zaer N, Shaw C, Chasen B, Avritscher R, Murthy R. Temporary balloon occlusion of the common hepatic artery for administration of yttrium-90 resin microspheres in a patient with patent hepatoenteric collaterals. J Vasc Interv Radiol 23(2):277-280, 2/2012. PMID: 22264555.
7. Avritscher R, Wright KC, Javadi S, Uthamanthil R, Gupta S, Gagea M, Bassett RL, Murthy R, Wallace MJ, Madoff DC. Development of a large animal model of cirrhosis and portal hypertension using hepatic transarterial embolization: a study in swine. J Vasc Interv Radiol 22(9):1329-1334, 9/2011. e-Pub 7/2011. PMID: 21802316.
8. Subbiah V, Murthy R, Anderson PM. [90Y]Yttrium microspheres radioembolotherapy in desmoplastic small round cell tumor hepatic metastases. J Clin Oncol 29(11):e292-e294, 4/2011. e-Pub 1/2011. PMCID: PMC3082986.
9. Salem R, Lewandowski RJ, Gates VL, Nutting CW, Murthy R, Rose SC, Soulen MC, Geschwind JF, Kulik L, Kim YH, Spreafico C, Maccauro M, Bester L, Brown DB, Ryu RK, Sze DY, Rilling WS, Sato KT, Sangro B, Bilbao JI, Jakobs TF, Ezziddin S, Kulkarni S, Kulkarni A, Liu DM, Valenti D, Hilgard P, Antoch G, Muller SP, Alsuhaibani H, Mulcahy MF, Burrel M, Real MI, Spies S, Esmail AA, Raoul JL, Garin E, Johnson MS, Benson AB, Sharma RA, Wasan H, Lambert B, Memon K, Kennedy AS, Riaz A, Technology Assessment Committee, Interventional Oncology Task Force of the Society of Interventional Radiology. Research reporting standards for radioembolization of hepatic malignancies. J Vasc Interv Radiol 22(3):265-278, 3/2011. PMID: 21353979.
10. Ahrar J, Gupta S, Ensor J, Ahrar K, Madoff DC, Wallace MJ, Murthy R, Tam A, Hwu P, Bedikian AY. Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanoma. Cancer Invest 29(1):49-55, 1/2011. PMID: 21166498.
11. Gupta S, Bedikian AY, Ahrar J, Ensor J, Ahrar K, Madoff DC, Wallace MJ, Murthy R, Tam A, Hwu P. Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: response, survival, and prognostic factors. Am J Clin Oncol 33(5):474-480, Oct, 10/2010. e-Pub 11/2009. PMID: 19935383.
12. Gupta S, Sultenfuss M, Romaguera JE, Ensor J, Krishnamurthy S, Wallace MJ, Ahrar K, Madoff DC, Murthy R, Hicks ME. CT-guided percutaneous lung biopsies in patients with hematologic malignancies and undiagnosed pulmonary lesions. Hematol Oncol 28(2):75-81, 6/2010. e-Pub 9/2009. PMID: 19728397.
13. Avritscher R, Krishnamurthy S, Ensor J, Gupta S, Tam A, Madoff DC, Murthy R, Hicks ME, Wallace MJ. Accuracy and sensitivity of computed tomography-guided percutaneous needle biopsy of pulmonary hilar lymph nodes. Cancer 116(8):1974-1980, 4/2010. e-Pub 2/2010. PMID: 20151422.
14. Gayed I, Wahba H, Nunez R, Murthy R. Effect of Y-90 SirSpheres therapy for multiple liver metastases in a variety of tumors. J Cancer Sci Ther 2(2):043-046, Mar, 3/2010.
15. Kobayashi K, Szklaruk J, Trent JC, Ensor J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, Hicks ME, Gupta S. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors. Am J Clin Oncol 32(6):574-581, Dec, 12/2009. e-Pub 7/2009. PMID: 19636238.
16. Brown DB, Gould JE, Gervais DA, Goldberg SN, Murthy R, Millward SF, Rilling WS, Geschwind JF, Salem R, Vedantham S, Cardella JF, Soulen MC, Society of Interventional Radiology Technology Assessment Committee and the International Working Group on Image-Guided Tumor Ablation. Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol 20(7 Suppl):S425-S434, Jul, 7/2009. PMID: 19560030.
17. Briere TM, Beddar S, Balter P, Murthy R, Gupta S, Nelson C, Starkschall G, Gillin MT, Krishnan S. Respiratory gating with EPID-based verification: the MDACC experience. Phys Med Biol 54(11):3379-3391, 6/2009. e-Pub 5/2009. PMID: 19436104.
18. Liu DM, Kennedy A, Turner D, Rose SC, Kee ST, Whiting S, Murthy R, Nutting C, Heran M, Lewandowski R, Knight J, Gulec S, Salem R. Minimally invasive techniques in management of hepatic neuroendocrine metastatic disease. Am J Clin Oncol 31(6):200-215, 4/2009. PMID: 19346815.
19. Jakobs TF, Hoffmann RT, Schrader A, Stemmler HJ, Trumm C, Lubienski A, Murthy R, Helmberger TK, Reiser MF. CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer. Cardiovasc Intervent Radiol 32(1):38-46, 1/2009. e-Pub 6/25/2008. PMID: 18575933.
20. Fong Y, Hapreet W, Leung T, Warner R, Pennington K, Kalayoglu M, Hall M, Rose S, Smith R, Liu D, Murthy R, Kennedy A, Nutting C, Salem R, Gulec S. Integration of radiomicrosphere therapy into the contemporary management strategies for primary and metastatic liver cancer: oncology expert opinions and recommendations. J Interv Onc 2:46-58, 2009.
21. Jakobs TF, Saleem S, Atassi B, Reda E, Lewandowski RJ, Yaghmai V, Miller F, Ryu RK, Ibrahim S, Sato KT, Kulik LM, Mulcahy MF, Omary R, Murthy R, Reiser MF, Salem R. Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90yttrium microspheres. Dig Dis Sci 53(9):2556-2563, 9/2008. e-Pub 1/2008. PMID: 18231857.
22. Kennedy AS, Dezarn WA, McNeillie P, Coldwell D, Nutting C, Carter D, Murthy R, Rose S, Warner RR, Liu D, Palmedo H, Overton C, Jones B, Salem R. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients. Am J Clin Oncol 31(3):271-279, 6/2008. PMID: 18525307.
23. Atassi B, Bangash AK, Lewandowski RJ, Ibrahim S, Kulik L, Mulcahy MF, Murthy R, Ryu RK, Sato KT, Miller FH, Omary RA, Salem R. Biliary sequelae following radioembolization with Yttrium-90 microspheres. J Vasc Interv Radiol 19(5):691-697, 5/2008. e-Pub 3/2008. PMID: 18440457.
24. Kamat PP, Gupta S, Ensor JE, Murthy R, Ahrar K, Madoff DC, Wallace MJ, Hicks ME. Hepatic arterial embolization and chemoembolization in the management of patients with large-volume liver metastases. Cardiovasc Intervent Radiol 31(2):299-307, Mar-Apr, 3/2008. PMID: 17922160.
25. Atassi B, Bangash AK, Bahrani A, Pizzi G, Lewandowski RJ, Ryu RK, Sato KT, Gates VL, Mulcahy MF, Kulik L, Miller F, Yaghmai V, Murthy R, Larson A, Omary RA, Salem R. Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay. Radiographics 28(1):81-99, Jan-Feb, 1/2008. PMID: 18203932.
26. Tam A, Krishnamurthy S, Pillsbury EP, Ensor JE, Gupta S, Murthy R, Ahrar K, Wallace MJ, Hicks ME, Madoff DC. Percutaneous image-guided splenic biopsy in the oncology patient: an audit of 156 consecutive cases. J Vasc Interv Radiol 19(1):80-87, 1/2008. PMID: 18192471.
27. Murthy R, Kamat P, Nunez R, Madoff DC, Gupta S, Salem R, Yao JC. Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization. J Vasc Interv Radiol 19(1):145-151, 1/2008. PMID: 18192482.
28. Jakobs TF, Hoffmann RT, Dehm K, Trumm C, Stemmler HJ, Tatsch K, La Fougere C, Murthy R, Helmberger TK, Reiser MF. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases. J Vasc Interv Radiol 19(8):1187-1195, 2008. PMID: 18656012.
29. Tam A, Wagner-Bartak NA, Wallace MJ, Murthy R. Liver abscess after inadvertent transhepatic transgression during percutaneous fluoroscopy-guided gastrostomy. Clin Radiol 63(6):731-735, 2008. e-Pub 11/2007. PMID: 18455567.
30. Jakobs TF, Hoffmann RT, Fischer T, Stemmler HJ, Tatsch K, La Fougere C, Murthy R, Reiser MF, Helmberger TK. Radioembolization in patients with hepatic metastases from breast cancer. J Vasc Interv Radiol 19(5):683-90, 2008. e-Pub 2008. PMID: 18440456.
31. Abdalla EK, Denys A, Hasegawa K, Leung TW, Makuuchi M, Murthy R, Ribero D, Zorzi D, Vauthey JN, Torzilli G. Treatment of large and advanced hepatocellular carcinoma. Ann Surg Oncol 15(4):979-985, 2008. e-Pub 1/2008. PMID: 18236115.
32. Murthy R, Eng C, Krishnan S, Madoff DC, Habbu A, Canet S, Hicks ME. Hepatic Yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab. J Vasc Interv Radiol 18(12):1588-1591, 12/2007. PMID: 18057297.
33. Wallace MJ, Murthy R, Kamat PP, Moore T, Rao SH, Ensor J, Gupta S, Ahrar K, Madoff DC, McRae SE, Hicks ME. Impact of C-Arm CT on hepatic arterial interventions for hepatic malignancies. J Vasc Interv Radiol 18(12):1500-1507, 12/2007. PMID: 18057284.
34. Gupta S, Hicks ME, Wallace MJ, Ahrar K, Madoff DC, Murthy R. Outpatient management of post biopsy pneumothorax with small-caliber chest tubes: factors affecting the need for prolonged drainage and additional interventions. Cardiovasc Intervent Radiol 31(2). e-Pub 12/2007. PMID: 18074173.
35. Brown DB, Gould JE, Gervais DA, Goldberg SN, Murthy R, Millward SF, Rilling WS, Geschwind JF, Salem R, Vedantham S, Cardella JF, Soulen MC. Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol 18(12):1469-1478, 12/2007. PMID: 18057279.
36. Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Nemcek AA, Kulik L, Geschwind JF, Murthy R, Rilling W, Liu D, Bester L, Bilbao JI, Kennedy AS, Omary RA, Salem R. Radioembolization with Y90 microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol 30(4):571-592, Jul-Aug, 7/2007. e-Pub 5/2007. PMID: 17516113.
37. Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, Benson A, Espat J, Bilbao JI, Sharma RA, Thomas JP, Coldwell D. Recommendations for radioembolization of hepatic malignancies using Yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 68(1):13-23, 5/2007. PMID: 17448867.
38. Murthy R, Brown DB, Salem R, Meranze SG, Coldwell DM, Krishnan S, Nunez R, Habbu A, Liu D, Ross W, Cohen AM, Censullo M. Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. J Vasc Interv Radiol 18(4):553-561, 4/2007. PMID: 17446547.
39. Gupta S, Henningsen JA, Wallace MJ, Madoff DC, Morello FA, Ahrar K, Murthy R, Hicks ME. Percutaneous biopsy of head and neck lesions with CT guidance: various approaches and relevant anatomic and technical considerations. Radiographics 27(2):371-390, Mar-Apr, 3/2007. PMID: 17374859.
40. Kennedy AS, Warner R, McNeillie P, Dezarnl WA, Coldwell D, Nutting C, Carter D, Murthy R, Rose S, Liu D, Overton C, Salem R. Radioembolization for neuroendocrine hepatic metastases. Cancer Investigation 25(1):55-56, 2007.
41. Kobayashi K, Gupta S, Trent JC, Vauthey JN, Krishnamurthy S, Ensor J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, McRae SE, Hicks ME. Hepatic artery chemoembolization for 110 gastrointestinal stromal tumors: response, survival, and prognostic factors. Cancer 107(12):2833-2841, 12/2006. PMID: 17096432.
42. Madoff DC, Gupta S, Ahrar K, Murthy R, Yao JC. Update on the management of neuroendocrine hepatic metastases. J Vasc Interv Radiol 17(8):1235-1249; quiz 1250, 8/2006. PMID: 16923972.
43. Kennedy AS, Coldwell D, Nutting C, Murthy R, Wertman DE, Loehr SP, Overton C, Meranze S, Niedzwiecki J, Sailer S. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 65(2):412-425, 6/2006. PMID: 16690429.
44. Kobayashi K, Murthy R, Madoff DC. Acute endovascular stent-graft occlusion after treatment of an arterio ureteral fistula. J Vasc Interv Radiol 16(10):1409-1410, 10/2005. PMID: 16221916.
45. Gupta S, Johnson MM, Murthy R, Ahrar K, Wallace MJ, Madoff DC, McRae SE, Hicks ME, Rao S, Vauthey JN, Ajani JA, Yao JC. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer 104(8):1590-1602, 10/2005. PMID: 16134179.
46. Madoff DC, Denys A, Wallace MJ, Murthy R, Gupta S, Pillsbury EP, Ahrar K, Bessoud B, Hicks ME. Splenic arterial interventions: anatomy, indications, technical considerations, and potential complications. Radiographics 25(Suppl 1):S191-211, 10/2005. PMID: 16227491.
47. Murthy R, Nunez R, Szklaruk J, Erwin W, Madoff DC, Gupta S, Ahrar K, Wallace MJ, Cohen A, Coldwell DM, Kennedy AS, Hicks ME. Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 25(Suppl 1):S41-S55, 10/2005. PMID: 16227496.
48. Murthy R, Xiong H, Nunez R, Cohen AC, Barron B, Szklaruk J, Madoff DC, Gupta S, Wallace MJ, Ahrar K, Hicks ME. Yttrium-90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol 16(7):937-945, 7/2005. PMID: 16002501.
49. Gupta S, Seaberg K, Wallace MJ, Madoff DC, Morello FA, Ahrar K, Murthy R, Hicks ME. Imaging-guided percutaneous biopsy of mediastinal lesions: different approaches and anatomic considerations. Radiographics 25(3):763-786; discussion 786-788, May-Jun, 5/2005. PMID: 15888624.
50. Gupta S, Krishnamurthy S, Broemeling LD, Morello FA, Wallace MJ, Ahrar K, Madoff DC, Murthy R, Hicks ME. Small (<2-cm) subpleural pulmonary lesions: short versus long needle path for computed tomography-guided biopsy of small pulmonary lesions: comparison of diagnostic yield and complications. Radiology 234(2):631-637, 2/2005. PMID: 15673500.
51. Madoff DC, Abdalla EK, Gupta S, Wu TT, Morris JS, Denys A, Wallace MJ, Morello FA, Ahrar K, Murthy R, Lunagomez S, Hicks ME, Vauthey JN. Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol 16(2 Pt 1):215-225, 2/2005. PMID: 15713922.
52. Ahrar K, Himmerich JU, Herzog CE, Raymond AK, Wallace MJ, Gupta S, Madoff DC, Morello FA, Murthy R, McRae SE, Hicks ME. Percutaneous ultrasound-guided biopsy in the definitive diagnosis of osteosarcoma. J Vasc Interv Radiol 15(11):1329-1333, 11/2004. PMID: 15525755.
53. Avritscher R, Madoff DC, Ramirez PT, Wallace MJ, Ahrar K, Morello FA, Gupta S, Murthy R, Wright KC, Hicks ME. Fistulas of the lower urinary tract: percutaneous approaches for the management of a difficult clinical entity. Radiographics 24(Suppl 1):S217-S236, 10/2004. PMID: 15486242.
54. Wallace MJ, Jean JL, Gupta S, Eapen GA, Johnson MM, Ahrar K, Madoff DC, Morello FA, Murthy R, Hicks ME. Inferior vena caval filters: survival in patients with malignancy. Cancer 101(8):1902-1907, 10/2004. PMID: 15386336.
55. Murthy R, Arbabzadeh M, Richard H, Levitin A, Lund G, Stainken B. Endovascular technique for revision of excess catheter length in subcutaneous implanted venous access devices. Cardiovasc Intervent Radiol 27(3):259-261, May-Jun, 5/2004. e-Pub 4/2004. PMID: 15108022.
56. Rundback JH, Dorfman G, Safriel Y, Mauro M, Wright K, Bonn J, Farahani K, Murthy R. Development of a research agenda for interventional oncology: proceedings from an interdisciplinary consensus panel. J Vasc Interv Radiol 15(1 Pt 1):7-12, 1/2004. PMID: 14709681.
57. Gupta S, Nguyen HL, Morello FA, Ahrar K, Wallace MJ, Madoff DC, Murthy R, Hicks ME. Various approaches for CT-guided percutaneous biopsy of deep pelvic lesions under CT guidance: anatomic and technical considerations. Radiographics 24(1):175-189, Jan-Feb, 1/2004. PMID: 14730045.
58. Gupta S, Madoff DC, Ahrar K, Morello FA, Wallace MJ, Murthy R, Hicks ME. CT-guided needle biopsy of deep pelvic lesions by extraperitoneal approach through iliopsoas muscle. Cardiovasc Intervent Radiol 26(6):534-538, Nov-Dec, 11/2003. PMID: 15061177.
59. Gupta S, Yao JC, Ahrar K, Wallace MJ, Morello FA, Madoff DC, Murthy R, Hicks ME, Ajani JA. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the MD Anderson experience. Cancer J 9(4):261-267, Jul-Aug, 7/2003. PMID: 12967136.
60. Sarkodee-Adoo C, Taran I, Guo C, Buadi F, Murthy R, Cox E, Lopez R, Westphal S, Shope S, O'Connell B, Wethers L, Meisenberg B. Influence of pre-apheresis clinical factors on the efficiency of CD34+ cell collection by large-volume apheresis. Bone Marrow Transplant 31(10):851-855, 5/2003. PMID: 12748660.
61. Safriel Y, Murthy R, Kergosien Y. The ACR-RSNA Fellowship in Clinical Trials of Medical Imaging: reflections from the 2002 recipients. Acad Radiol 10(5):565-566, 5/2003. PMID: 12755547.
62. Sarfaraz M, Kennedy AS, Cao ZJ, Sackett GD, Yu CX, Lodge MA, Murthy R, Line BR, Van Echo DA. Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors. Med Phys 30(2):199-203, 2/2003. PMID: 12607837.
63. Murthy R, Arbabzadeh M, Richard H, Levitin A, Lund G, Stainken B, Cooper C. Axillary artery traumatic pseudoaneurysm managed with a Wallgraft Endoprothesis. J Vasc Interv Radiol 14(1):117-118, 1/2003. PMID: 12525598.
64. Murthy R, Arbabzadeh M, Lund G, Richard H, Levitin A, Stainken B. Percutaneous transrenal hemodialysis catheter insertion. J Vasc Interv Radiol 13(10):1043-1046, 10/2002. PMID: 12397127.
65. Murthy R,Wesley BA, Coldwell DM. Totally implanted venous access device removal in interventional radiology. Clin Radiol 57(9):850-852, 9/2002. PMID: 12384113.
66. Murthy R. New horizons in oncologic embolotherapy. J Vasc Interv Radiol 13(2):P116-P123, Feb, 2/2002.
67. Richard HM, Hastings GS, Boyd-Kranis RL, Murthy R, Radack DM, Santilli JG, Ostergaard C, Coldwell DM. A randomized, prospective evaluation of the Tesio, Ash split, and Opti-flow hemodialysis catheters. J Vasc Interv Radiol 12(4):431-435, 4/2001. PMID: 11287528.
68. Richard HM, Coldwell DM, Boyd-Kranis RL, Murthy R, Van Echo DA. Pleurx tunneled catheter in the management of malignant ascites. J Vasc Interv Radiol 12(3):373-375, 3/2001. PMID: 11287517.

Invited Articles

1. Avritscher R, de Baere T, Murthy R, Deschamps F, Madoff D. Percutaneous transhepatic portal vein embolization: rationale, technique, and outcomes. Semin Interv Radiol 25:132-145, 2008.
2. Murthy R, Kamat P, Nunez R, Salem R. Radioembolization of Yttrium-90 microspheres for hepatic malignancy. Semin Interv Radiol 25(1):48-57, 2008.
3. Salem R, Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Ibrahim S, Nemcek AA, Omary RA, Madoff DC, Murthy R. Technical aspects of radioembolization with 90Y microspheres. Tech Vasc Interv Radiol 10(1):12-29, 2007. PMID: 17980315.
4. Murthy R, Habbu A, Salem R. Trans-arterial hepatic radioembolization yttrium-90 microspheres. Biomed Imaging Interv J 2(3):e43:1-10, 2006.
5. Wallace MJ, Murthy R. Transarterial therapy for patients with hepatic malignancy. Semin Interv Radiol 22:316-328, 2005.
6. Murthy R, Hastings GS, Richard HM III, Levitin A. Angiography and endovascular intervention for vascular trauma to the extremities. Semin Interv Radiol 20:81-88, 2003.

Editorials

1. Murthy R, Szklaruk J. Invited commentary. Radiographics 25(Suppl 1):S97-S98, Oct, 10/2005.
Other Articles
1. Gamblin CT, Murthy R. Small beads, big hope - radioembolization with microspheres targets liver cancer. Radiology Today 9(14):26, 2008.

Abstracts

1. Subbiah V, Murthy R, Hosing C, Kaur I, Falchook G, Bosch M. DCVax®- direct: autologous activated dendritic cells for image guided intra-tumoral vaccination in patients with solid tumors - a phase I/II clinical trial in progress. Proceedings of Society of Immunotherapy of Cancer (SITC) 28th Annual Meeting. In Press.
2. Black B, Jones AK, Mahvash A, Odisio BC, Avritscher R, Ensor J, Murthy R, Steele JR. Impact of a novel balloon occlusion technique on fluoroscopy time and radiation dose using Y90 radioembolization. Proceedings of the 2014 Society of Interventional Radiology Annual Scientific Meeting. In Press.
3. Mahvash A, Odisio BC, Avritscher R, Chasen B, Murthy R. Temporary balloon occlusion of the common hepatic artery during Y90 radioembolization. Proceedings of the 2014 Society of Interventional Radiology Annual Scientific Meeting. In Press.
4. Enriquez J, Javadi S, Murthy R, Ensor J, Mahvash A, Abdelsalam ME, Madoff DC, Wallace MJ, Avritscher R. Gastroduodenal artery recanalization after transcatheter fibered coil embolization for prevention of hepaticoenteric flow: Incidence and predisposing technical factors in 142 patients. Acta Radiol 54(7):790 - 794, 9/2013. e-Pub 4/30/2013. PMID: 23535183.
5. Shreyaah S, Odisio BC, Garrett C, Avritscher R, Murthy R. KRAS mutant metastatic colorectal cancer;is there a role for Yttrium-90 microsphere radioembolotherapy?. JVIR (Supplement) 24(4):S112 - S113 (#254), 4/2013.
6. Gadani S, Mahvash A, Avritscher R, Chasen B, Kaseb A, Murthy R. Yttirum-90 resin microspheres as an adjunct to sorafenib in patients with unresectable HCC: a retrospective study for evaluation of survival benefit and adverse events. JVIR (Supplement) 24(4):S35 (#62), 4/2013.
7. Mahvash A, Murthy R. Yttrium - 90 microsphere radioembolotherapy for adolescent hepatic malignancies: Early experience at MD Anderson Cancer Center. Proceedings of the 5th Pediatric Interventional Radiology Symposium at the Hospital for Sick Children, Toronto, 10/2012.
8. Maclellan C, Hobbs BP, Chasen B, Murthy R, Mahvash A, Kappadath SC. Absorbed dose differences in 90Y microsphere therapy between pre-treatment 99m Tc-MAA and post-treatment 90Y scans. J Nuclear Medicine(53(Supplement 1)):323, 6/2012.
9. Enriquez J, Javadi S, Ensor J, Murthy R, Mahvash A, Abdelsalam M, Madoff D, Wallace MJ, Avritscher R. Gastroduodenal artery recanalization after transcatheter fibered coil embolization for prevention of hepaticoenteric flow: Incidence and predisposing technical factors in 142 patients. GEST 2012 U.S. Abstracts - JVIR:577.e4, http://download.journals.elsevierhealth.com/pdfs/journals/1051-0443/PIIS1051044312002059.pdf, 4/2012.
10. Mahvash A, Moayyad J, Shreyaah S, Avritscher R, Murthy R. Y90 radioembolization in patients with compromise of the ampulla of vater. GEST 2012 U.S. Abstracts - JVIR:577.e12, http://download.journals.elsevierhealth.com/pdfs/journals/1051-0443/PIIS1051044312002059.pdf, 4/2012.
11. Mahvash A, Shreyaah S, Chasen B, Avritscher R, Murthy R. Balloon-catheter occlusion technique for administration of Y90 microspheres in patients with patent hepatoenteric arteries. J Vasc Interv Radiol Supplement 23(3S):S67 - S68 (#161), http://www.jvir.org/article/S1051-0443(11)01826-4/fulltext, 3/2012.
12. Kuban JD, Philip AS, Chen GJ, Joseph Jr E, Tam AL, Wallace MJ, Avritscher R, Ahrar JU, Ahrar K, Murthy R, Mahvash A, McRae SE, Gupta S. Effect of needle size on pneumothorax and chest tube placement rates in CT-guided percutaneous lung biopsies performed using a coaxial method: a large single-center study. J Vasc Interv Radiol Supplement 23(3S):S27 - S28 (#60), 3/2012.
13. McCann J, Larkin A, Moore L, Johnson M, Sze D, Kwofie J, Saad N, Parikh P, Murthy R, Erin W, Kolbeck K, Franco J, Brown D. Multi-center correlation of external exposure rates from 90Y radioembolization patients: contact precautions are unnecessary based on Nuclear Regulatory Commission regulations. J Vasc Interv Radiol Supplement 23(3S):S68 - S69 (#164), http://www.jvir.org/article/S1051-0443(11)01829-X/fulltext, 3/2012.
14. Speer M, Abdelsalam M, Chasen B, Murthy R, Mahvash A, Avritscher R. The retroportal artery and other less well-known hepatoenteric pathways: moving beyond GDA and right gastric embolization. J Vasc Interv Radiol Supplement 23(3S):S151 (#378), http://www.jvir.org/article/S1051-0443(11)02117-8/fulltext, 3/2012.
15. Neperud J, Mahvash A, Garg N, Murthy R, Szklaruk J. Imaging pattern of neuroendocrine tumor hepatic metastases as a predictor of response to yttrium-90 radioembolotherapy. WCIO 2011 Annual Conference, 6/2011.
16. Murthy R, Mahvash A, Phan A, James Y, Wallace MJ. Y90 resin microsphere arterial redioembolotherapy as a therapeudic adjunct to systemic biologic therapy for advanced hepatic metastic neuroendocrine tumor progression. Proceedings of World Conference on Interventional Radiology, 6/2011.
17. Avritscher R, Wright KC, Gagea-Iurascu M, Murthy R, Madoff M. Development of a large animal model for liver cirrhosis. Proceedings of the 35th Annual Scientific Meeting of The Society of Interventional Radiology 21(2S):S76 (#197), 2010.
18. Murthy R, Wallace M, Madoff DC, Avritscher R, Mahvash A. Quantification of hepatopulmonary shunting using C-Arm CT: potential implications for Y90 microsphere radioembolotherapy program. Proceedings of the World Conference on Interventional Oncology 2010 Annual Meeting, 2010.
19. Murthy R, Mahvash R, Avritscher, Erwin W, Chasen B., Eng C. Yttrium microspheres with cituximab plus irinotecan for patients with advanced colorectal cancer metastases to liver. J Clin Oncol 28(15s):TPS197 (#TPS197), 2010. e-Pub 8/2009.
20. Mutha P, Madoff D, Mahvash A, Avritscher R, Murthy R. Extrahepatic progression of hepatic-only colorectal cancer: impact on combinatorial (systemic + local therapy) clinical trial design. Proceedings of the 34th Annual Meeting of Society of Interventional Radiology 20(2S):S63 (#162), Feb, 2/2009.
21. Kappadath S, Erwin W, Mutha P, Prasad S, Murthy R. Comparison of three radiation dosimetry models for yttrium-90 microsphere. Proceedings of the Society of Nuclear Medicine Annual Meeting, 2009.
22. Gupta S, Wallace M, Ahrar K, Madoff D, Murthy R, Hicks M, Suitor C, McEnery K, Patel J. Integration of online reporting system for interventional radiology procedure-related complications with the digital dictation system: early experience. J Vasc Interv Radiol 20(2):S41-S42 (#105), 2009.
23. Mutha P, Madoff D, Mahvash A, Avritscher R, Murthy R. Patterns of disease progression of colorectal cancer: a systematic review of the MD Anderson Cancer Center Tumor Registry. Proceedings of the 4th Interventional Symposium on Regional Cancer Therapies Conference, 2009.
24. Avritscher R, Madoff D, Murthy R, Mahvash A, Wallace M. Adjunctive use of c-arm cone-beam ct during percutaneous gastrostomy insertion may help increase safety and technical success rate in patients with difficult access. Proceedings of the Radiological Society of North America Annual Meeting, 2008.
25. Mutha P, Murthy R. Can percutaneous hepatic artery infusional chemotherapy procedures be safely performed with concomitant systemic bevacizumab therapy?. Proceedings of the Third International Symposium on Regional Cancer Therapies Annual Meeting, 2008.
26. Mutha P, Macapinlac H, Kamat P, Madoff DC, Gupta S, Ahrar K, Wallace M, Murthy R. Continued role of Tc 99m MAA scintigraphic detection of extrahepatic perfusion prior to initiating percutaneous trans-catheter hepatic artery chemotherapy. AJR Am J Roentgenol 190(4 Supplement, A52), 2008.
27. Mutha P, Madoff DC, Gupta S, Avritscher R, Murthy R. Hepatic metastatic colorectal cancer patients with advanced disease appear to exhibit poor response rates to Y90 hepatic radioembolotherapy. Proceedings of the Radiomicrosphere Therapy 4th Annual Symposium, 2008.
28. Verma R, Singh S P, Murthy R, Kundra V. In vitro activation of radiation sensitive promoter (Egr-1) via radiation from Y-90 microspheres. J Vasc Interv Radiol 19(2):S47, 2008.
29. Clyde S, Wei A, Murthy R. Is the inability to achieve procedure related pain control influenced by pre-procedure narcotic use?. J Vasc Interv Radiol 19(2):S34 (#84), 2008.
30. Madoff DC, Abdalla EK, Wallace MJ, Murthy R, Ahrar K, Gupta S, Wei SH, Hicks ME, Vauthey JN. Sequential transcatheter arterial chemoembolization and portal vein embolization before hepatectomy for patients with hepatocellular carcinoma. Cardiovasc Interv Radiol 29(Suppl 1)(S202), 2008.
31. Gayed I, Murthy R. Treatment of multiple liver metastases with Y-90 SIR Spheres: The experience of a large cancer center (Therapy, Metrics & Intervention Posters). Proceedings of the Society of Nuclear Medicine Annual Meeting (#1421), 2008.
32. Kamat PP, Camacho L, Madoff DC, Gupta S, Murthy R. Gastrointestinal toxicity associated with hepatic artery infusional chemotherapy is not prevented by the exclusion of extrahepatic perfusion as demonstrated by pre-therapy arteriography and nuclear scintigraphy. Proceedings of the Radiological Society of North America Scientific Assembly and Annual Meeting Program:293 (#SSC03-02), 2007.
33. Murthy R, Oh Y, Tam A, Gupta S, Madoff DC, Glisson B. Yttrium-90 microsphere treatment for liver dominant hepatic metastases from lung cancer. J Clin Oncol 24(18s):17122 (#17122), Jun, 6/2006.
34. Kobayashi K, Gupta S, Trent J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, McRae SE, Hicks ME. Hepatic artery chemoembolization in patients with metastatic gastrointestinal stromal tumors refractory to imatinib. J Vasc Interv Radiol 17:S77-S78, 2006.
35. Murthy R, Habbu A, Richey S, Eng C. Implications of patterns of metastases of mCRC on liver directed therapy in patients undergoing combination systemic treatment with irinotecan and cetuximab. Proceedings of the World Conference on Interventional Oncology, Annual Meeting, 2006.
36. Murthy R, Xiong H, Eng C, Habbu A, Canet S, Hicks M. Yttrium-90 microsphere liver directed therapy in patients with metastatic colorectal cancer following failure of cetuximab and bevacizumab. Proceedings of the World Conference on Interventional Oncology, Annual Meeting, 2006.
37. Murthy R, Gupta S, Madoff D, Nunez R, Yao J, Szklaruk J. Feasibility of hepatic arterial therapy with Yttrium-90 microspheres, SIR-Spheres, in metastatic neuroendocrine neoplasia with hepatic dominant progression after failure of multiple systematic and hepatic artery therapies. Proceeding of the Radiological Society of North America (RSNA) Annual Meeting. e-Pub 2005.
38. Gupta S, Johnson MM, Murthy R, Wallace MJ, Madoff DC, McRae SE, Hicks ME, Rao S, Vauthey JN, Ajani JA, Yao JC. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer 104(8):1590-1602, 2005. PMID: 16134179.
39. Morello FA Jr, Rao SH, Harle MT, Mobley GM, Murthy R, Cleeland C. Pain quantification and patient satisfaction in Interventional Radiology. Proceedings of the 2005 Society of Interventional Radiology 30th Annual Scientific Meeting (#186), 2005.
40. Madoff DC, Abdalla E, Gupta S, Tsung-Teh W, Morris JS, Denys a, Wallace M, Morello F, Ahrar K, Murthy R, Lunagomez S, Hicks ME, Vauthey N,. Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol 16(2 (Pt1)):215-25, 2005. PMID: 15713922.
41. Murthy R, Nunez R, Szklaruk F, Erwin W, Madoff DC, Gupta S, Ahrar K, Wallace M, Cohen A, Coldwell D, Kennedy A, Hicks ME. Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 25(Suppl 1):S41-55, 2005. PMID: 16227496.
42. Madoff DC, Wallace MJ, Murthy R, Gupta S. Splenic arterial interventions: anatomy, indications, technical considerations, and potential complications. Radiographics 25(Suppl 1):S191-211 (#1578VI-e), 2004. PMID: 16227491.
43. Gupta S, Yao JC, Ahrar K, Wallace MJ, Morello FA, Madoff DC, Murthy R, Hicks ME, Ajani JA. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience. Cancer J 9(4):261-7, 2003. PMID: 12967136.
44. Murthy R, Kennedy AS, Line BR, Lund GB, Stainken B, Van Echo DA, et al. Augmentation of hepatopulmonary shunting following trans-arterial hepatic brachytherapy (TAHB) with Yttrium-90 25µm spheres: TheraSphere® -therapeutic implications. Proceedings of the 88th Annual Meeting of the Radiological Society of North America 225:307 (#283), 2002.
45. Murthy R, Line B, Kennedy AS, Stainken BF, Mourtzikos K, Van Echo DA. Clinical utility of Brehmstralung scan (BRM-scan) after TheraSphere (TS) (MDS Nordion, Kanata, Canada) administration. Proceedings of the Society for Cardiovascular and Interventional Radiology Annual Meeting, 2002.
46. Kennedy AS, Murthy R, Safaraz M, Yu C, Ma L, Van Echo D. Outpatient (MDS Nordion, Canada) administration. Proceedings of the Society of Cardiovascular and Interventional Radiology Annual Meeting, 2002.
47. Murthy R, Kennedy AS, Coldwell DM, Lund G, Stainken BF, Van Echo DA. Technical aspects of TheraSphere (TS) infusion (MDS Nordion, Kanata, Canada). Proceedings of the Society for Cardiovascular and Interventional Radiology Annual Meeting, 2002.
48. Murthy R, Kennedy AS, Coldwell DM, Lund G, Stainken BF, Van Echo DA. Trans-arterial brachytherapy for hepatic malignancies utilizing particle emitting Yttrium-90 microspheres. Proceedings of the Society for Cardiovascular and Interventional Radiology Annual Meeting, 2002.
49. Murthy R, Boyd-Kranis RL, Hastings GS, Coldwell DM, Radack D, Santilli JG. Feasibility of trapease inferior vena cava (IVC) filter insertion using single venous puncture and intravascular ultrasound (IVUS) guidance. Proceedings of the Annual Meeting and Postgraduate Course Cardiovascular and Interventional Radiology Society of Europe, 2001.
50. Coldwell DM, Van Echo D, Kennedy A, Murthy R, Boyd-Dranis R, Hastings G. Feasibility of treatment of hepatic tumors utilizing embolization with yttrium-90 glass microspheres. Proceedings of the Society of Cardiovascular and Interventional Radiology Annual Meeting, 2001.
51. Murthy R, Boyd-Kranis RL, Hastings GS, Coldwell DM, Radack DM, Stainken BF. Hepatic vein hemodynamic assessment predicts pathological finding at transjugular liver biopsy. Proceedings of the Annual meeting and Postgraduate Course Cardiovascular and Interventional Radiological Society of Europe, 2001.
52. Murthy R, Sarkodee-Adoo C, Scholfield K. Lowering patient transfusion threshold requirements for tunneled central venous catheter (TCVC) insertion: Interim results. Proceedings of the American Society of Hematology Annual Meeting, 2001.
53. Murthy R, Kennedy AS, Tucker G, Murthy A, Van Echo D. Outpatient trans arterial hepatic low dose rate brachytherapy for unresectable hepatocellular carcinoma. Proceedings of the American Association for Cancer Research Annual Meeting, 2001.
54. Kennedy A, Murthy R, Van Echo D. Preliminary results of outpatient hepatic artery brachytherapy for colorectal hepatic metastases. Proceedings of the European Conference on Clinical Oncology Annual Meeting, 2001.
55. Murthy R, Schofield K, Wesley B, Bouchelle Z, Lloyd P, Richard HM III. Safety & Feasibility of ultrasound & fluoroscopic assisted PICC line insertion (UFPI) by a team of nurse's functioning under the aegis of interventional radiology (IR). Proceedings of the Radiological Society of North America Annual Meeting, 2001.
56. Van Echo DA, Kennedy AM, Coldwell DM, Murthy R, Sarfaraz M, Line B. TheraSphere (TS) for mixed hepatic cancers at 143 Gy median dose, feasibility and toxicities. Proceedings of the American Society of Clinical Oncology, 2001.
57. Kennedy AS, Murthy R, Kwok Y, Tucker G, Kanani S, K Desai BS, Van Echo DA. TheraSphere for hepatocellular carcinoma. Proceedings of the International Conference on Cancer Therapy Annual Meeting, 2001.
58. Coldwell DM, Van Echo D, Murthy R, Boyd-Kranis R, Hastings GS, Radack D. Treatment of radio-resistant head and neck squamous cell carcinomas (HNSCC) with super selective intra-arterial infusion of platinol. Proceedings of the Society of Cardiovascular and Interventional Radiology Annual Meeting, 2001.
59. Richard HM III, Hastings GS, Boyd-Kranis RL, Murthy R, Radack DM, Santilli JG. A randomized prospective evaluation of the Tesio, Ash split and Bard Optiflow hemodialysis catheters. Proceedings of the Society of Cardiovascular and Interventional Radiology Annual Meeting, 2000.
60. Boyd-Kranis RL, Hastings GS, Coldwell DM, Murthy R, Santilli JG, Radack D. Blunt Splenic Injury: the use of angiography and embolization for nonoperative treatment. Proceedings of the Society of Cardiovascular and Interventional Radiology Annual Meeting, 2000.
61. Grigorev I, O'Connell B, Cottler-Fox M, Murthy R, Chen T, Meisenberg B, Sarkodee-Adoo C. Factors affecting the efficiency of stem cell collection by apheresis: a multivariate analysis. Proceedings of the American Society of Hematology Annual Meeting, 2000.
62. Richard HM III, Coldwell DM, Hastings GS, Boyd-Kranis RL, Murthy R, Radack DM. Pleurx tunneled catheter in the management of malignant ascites. Proceedings of the Society of Cardiovascular and Interventional Radiology Annual Meeting 12(3):373-5, 2000.
63. Murthy R, Boyd-Kranis RL, Hastings GS, Coldwell DM, Radack D, Santilli JG. Tunneled central venous catheter insertion in patients with thrombocytopenia. Proceedings of the Society of Vascular Medicine and Biology Annual Meeting, 2000.
64. Hastings GS, O'Connor D, Boyd-Kranis RL, Murthy R, Pais SO, Coldwell DM. Bleeding complications of translumbar hemodialysis catheter insertion. Proceedings of the American Roentgen Ray Society Annual Meeting, 1999.
65. Hastings GS, Boyd-Kranis RL, Murthy R, Santilli JG, Pais SO, Coldwell DM. Compulsory use of Site-Rite sonographic guidance for low internal jugular vein access eliminates major puncture-related complications. Proceedings of the Annual Meeting and Postgraduate Course Cardiovascular and Interventional Radiological Society of Europe, 1999.
66. Hastings GS, Santilli JG, Boyd-Kranis RL, Murthy R, Pais SO, Coldwell DM. Lace and go thrombolysis for dialysis grafts. Proceedings of the Society for Cardiovascular and Interventional Radiology Annual Meeting, 1999.
67. Hastings G, Markert D, Boyd-Kranis R, Murthy R, Pais O, Coldwell D. Rotational angiography in trauma. Proceedings of the Annual Meeting and Postgraduate Course Cardiovascular and Interventional Radiological Society of Europe, 1999.

Book Chapters

1. Odisio BC, Murthy R. Image-guided therapies for hepatocellular carcinoma. In: Hepatocellular carcinoma - future outlook. InTech - Open Access Publisher, 2013.
2. Murthy R, Mutha P, Gupta S. Yttrium 90 radioembolotherapy for hepatocellular cancer. In: Hepatocellular Carcinoma. Springer Science Business Media, LLC: Totowa, New Jersey, 2010.
3. Murthy R. Contribution - Radioembolization for hepatocellular cancer. In: Hepatocellular Carcinoma: a multidisciplinary approach. Springer, 2009.

Books (edited and written)

1. Murthy R. Clinical Interventional Oncology. Elsivier. In Press.

Letters to the Editor

1. Murthy R, Mutha P, Madoff DC, Mahvash A, Erwin W. Establishment of the radiation effect of yttrium-90 microspheres: role of C-Arm CT. J Vasc Interv Radiol 20(3):422-424, 3/2009. e-Pub 1/2009. PMID: 19167244.
2. Murthy R, Mutha P, Lee JH, Oh Y. Yttrium-90 labeled microsphere radioembolotherapy of liver-dominant metastases from thoracic malignancies. J Vasc Interv Radiol 19(2)(2 Pt 1):299-302, 2/2008. PMID: 18341967.
3. Murthy R, Kamat P, Staerkel G. Podagra. Internet Journal of Radiology 6(1), 2007.
4. Murthy R, Arbabzadeh M, Richard H, Levitin A, Lund GA, Stainken B, Cooper C. Axillary artery traumatic pseudoaneurysm managed with a Wallgraft endoprosthesis. J Vasc Interv Radiol 14:117-118, 1/2003.

Manuals, Teaching Aids, Other Teaching Publications

1. Kennedy A, Nag S, Murthy R, Dezarn W, Nutting C, Coldwell D, Salem R, Liu D. Liver-directed radiotherapy using microspheres (radioembolization) for primary and metastatic cancers, 2008.
2. Coldwell D, Murthy R, Nutting C, Salem R. Practice guideline for radioembolization with microsphere brachytherapy device (TMBD) for treatment of liver malignancies: American College of Radiology Guidelines, 2008.
3. Murthy R, Jakobs T. Spheres of progress in cancer treatment. 20(19). Merion Publications: King of Prussia, PA, 27, http://imaging-radiology-oncology-echnologist.advanceweb.com/common/EditorialSearch/AViewer.aspx?AN=XT_07sep3_xtp27.html&AD=09-03-2007, 2007.
4. Salem R, Kulik L, Murthy R. Radioembolization with Yttrium-90 microspheres for the treatment of hepatocellular carcinoma and liver metastases: Touch Briefings website - US Gastroenterology Review, 2:48-50, 2006.
5. Murthy R. Radiotherapy with microspheres showcases latest research on microsphere therapy. East Valley Living Articles, 2006.
6. Murthy R. Irradiated microspheres lead to palliative option for unresectable liver cancer, http://wwwdimag.com/dinews/2001033001.htm, 2001.
7. Murthy R. Emergency Medicine Bulletin Board System, www.EMBBS.com, 2000.
 

Other

1. Poster. Odisio BC, Shreyaah S, Mahvash A, Avritscher R, Chasen B, Murthy R, Garrett C. KRAS mutant metastatic colorectal cancer;is there a role for Yttrium-90 microsphere radioembolotherapy? 38th Annual Meeting of the Society of Interventional Radiology, 04/2013.
2. Poster. Subbiah V, Murthy R, Hosing C, Kaur I, Falchook G, Bosch M. DCVax®- DIRECT: Autologous activated Dendritic cells for Image guided Intra-tumoral vaccination in patients with Solid Tumors - A Phase I/II Clinical trial in progress. The Society for Immunotherapy of Cancer (SITC) 28th Annual Meeting. 11/2013.
3. Guidelines.

ACR–SIR Practice Guideline for Radioembolization with Microsphere Brachytherpy Device (RMBD) for Treatment of Liver Malignancies. 06/2013

http://www.acr.org/~/media/d8086059b5f541e9b64e55d68a71693b.pdf

.
4. Poster. Gadani S, Avritscher R, Odisio BC, Murthy R, Mahvash A. Infectious complications of Y90 radioembolization in patients with surgical bilioenteric anastamosis or compromised sphincter of oddi: the md anderson experience. The World Conference of Interventional Oncology Annual Meeting. 05/2013..

Grant & Contract Support

Title: Temsirolimus with metformin in PI3 CA /RAS RAF mutant endometrial patients
Funding Source: NIH/NCI
Role: Collaborator
Principal Investigator: Aung Naing, MD
Duration: 12/1/2013 - 11/30/2016
 
Title: Subintimal Angioplasty - Application for limb salvage in renal transplant recipients with critical limb ischemia
Funding Source: Burroughs Welcome Research Travel Grant
Role: Principal Investigator
Duration: 5/1/2008 - 5/12/2012
 
Title: Yttrium-90 microspheres (SIR-Spheres,,μ) therapy for the treatment of unresectable hepatocellular carcinoma
Funding Source: Sirtex Medical
Role: Principal Investigator
Duration: 12/11/2006 - 12/31/2008
 
Title: Phase II trial of SIR-Spheres, yttrium microspheres with cetuximab plus irinotecan for patients with advanced colorectal cancer metastases to liver
Funding Source: Sirtex Medical
Role: Principal Investigator
Duration: 12/11/2006 - 12/31/2008

Last updated: 9/5/2014